Engineered CAR-T cells block key protein to break solid tumors' immune shield
Medical Xpress
March 4, 2026
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block their attack, and fuel tumor growth.
Verticals
healthmedical
Originally published on Medical Xpress on 3/4/2026